PLK1 and its role in the evolving landscape of KRAS-mutated colorectal cancer

被引：1
|
作者：
Harvey, Harry [1 ]
Chen, Eric Xueyu [1 ]
机构：
[1] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, 7-824,700 Univ Ave, Toronto, ON M5G 1Z5, Canada
来源：
JOURNAL OF GASTROINTESTINAL ONCOLOGY | 2024年 / 15卷 / 04期
关键词：
Kirsten rat sarcoma virus (KRAS); colorectal cancer (CRC); targeted therapy; RAS; INHIBITOR; FOLFIRI; BEVACIZUMAB; GEMCITABINE; COMBINATION; ISIS-2503;
D O I：
10.21037/jgo-24-323
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1987 / 1992
页数：6
相关论文
共 50 条
  • [41] Realities of KRAS-mutated non-small cell lung cancer
    Min, Young Joo
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (03): : 442 - 442
  • [42] Immune landscape and prognostic immune-related signature in KRAS-mutated lung adenocarcinoma
    Peng, Xinyi
    Xia, Zhenqi
    Guo, Yong
    Li, Yan
    AGING-US, 2023, 15 (11): : 4889 - 4905
  • [43] MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer
    Yamasaki, Juntaro
    Hirata, Yuki
    Otsuki, Yuji
    Suina, Kentaro
    Saito, Yoshiyuki
    Masuda, Kenta
    Okazaki, Shogo
    Ishimoto, Takatsugu
    Saya, Hideyuki
    Nagano, Osamu
    CANCER SCIENCE, 2022, 113 (03) : 916 - 925
  • [44] MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer
    Yamasaki, Juntaro
    Otsuki, Yuji
    Masuda, Kenta
    Saya, Hideyuki
    Nagano, Osamu
    CANCER SCIENCE, 2023, 114 : 296 - 296
  • [45] Targeting Plk1 for cancer therapy
    Schmidt, Mathias
    Hofmann, Hans-Peter
    Sanders, Karl
    Gekeler, Volker
    Beckers, Thomas
    EJC SUPPLEMENTS, 2006, 4 (06): : 16 - 16
  • [46] The Potential Treatment Options and Combination Strategies of KRAS-Mutated Lung Cancer
    Zhao, Xinchao
    Zheng, Yawen
    Wang, Yufeng
    Zhang, Mingyan
    Dong, Zhilin
    Liu, Yanan
    Sun, Meili
    ONCOTARGETS AND THERAPY, 2024, 17 : 1041 - 1057
  • [47] Recent Progress on the Localization of PLK1 to the Kinetochore and Its Role in Mitosis
    Kim, Taekyung
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (09)
  • [48] MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer
    Yamasaki, Juntaro
    Otsuki, Yuji
    Masuda, Kenta
    Saya, Hideyuki
    Nagano, Osamu
    CANCER SCIENCE, 2023, 114 : 377 - 377
  • [49] Response to comment on ‘KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer’
    K-L G Spindler
    N Pallisgaard
    R F Andersen
    A Jakobsen
    British Journal of Cancer, 2014, 111 : 2380 - 2380
  • [50] SK4 oncochannels regulate calcium entry and promote cell migration in KRAS-mutated colorectal cancer
    Ibrahim, Sajida
    Chaigne, Justine
    Dakik, Hassan
    Fourbon, Yann
    Corset, Laetitia
    Lecomte, Thierry
    Raoul, William
    Gueguinou, Maxime
    CELL CALCIUM, 2021, 96
12345